Organization · Corporate Venture Capital
Synapto Ventures
Synapto Ventures is a Singapore-based corporate finance boutique specializing in life sciences, providing strategic fundraising guidance and access to global investors. It offers a subscription-based fundraising package tailored for life science companies.
Overview
What Synapto Ventures does
What Synapto Ventures is
Synapto Ventures is a Singapore-based corporate finance boutique specializing in life sciences, providing strategic fundraising guidance and access to global investors. It offers a subscription-based fundraising package tailored for life science companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Corporate Venture Capital
- Founded
- Founded in 2013
- Approximate age
- About 13 years
- Structured capabilities
- Funder
- Last reviewed
- May 3, 2026
Official channels
Find Synapto Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Synapto Ventures as a funder
Investment thesis
Synapto Ventures empowers life-science companies by providing strategic financial guidance and access to a global network of investors, focusing on investor-ready materials and comprehensive fundraising support.
Focus narrative
Synapto Ventures invests in life science companies across multiple stages, from early to late-stage. Their unique offering, Quantum Leap Capital Raising™, is a subscription-based fundraising package that provides comprehensive support, including investor outreach and strategic improvement roadmaps, tailored to the needs of life science innovators.
Value beyond capital
Synapto Ventures adds value to its portfolio companies by providing strategic financial guidance, investor-ready materials, and access to a global network of investors. Their Quantum Leap Capital Raising™ program offers tailored support for fundraising efforts, ensuring that companies are well-prepared to engage with potential investors.
Terms and economics
- Typical check
- $10,000
Focus and fit
- Stages
- Growth Equity
- Regions
- Global · Europe · United States · Apac
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 6
Portfolio context
Notable portfolio companies include PamGene / PamDx, which recently raised EUR 13M for its immunotherapy test platform; OncoSpherix; Herantis Pharma; Curlim; BloodScan Biotech; and EXO-HARVEST. These companies represent a diverse range of innovations within the life sciences sector.
Common questions
What to know about Synapto Ventures
Upseed classifies Synapto Ventures under the Corporate Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.